Upload
Featured Recent Articles Topics Login Upload

Search Results for 'therapy grade'

therapy grade published presentations and documents on DocSlides.

Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma:
Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma:
by eddey
An ASTRO Clinical Practice Guideline. Developed in...
Antithrombotic Therapy for VTE:
Antithrombotic Therapy for VTE:
by olivia-moreira
CHEST Guidelines 2016. Jennifer . Mah. , MD. Marc...
Purpose Minimal Acute Toxicities Following High-Dose Proton Therapy for Spinal Tumors
Purpose Minimal Acute Toxicities Following High-Dose Proton Therapy for Spinal Tumors
by emily
Materials and Methods. Conclusion. Patients . t. r...
Alexander Olinger , PharmD
Alexander Olinger , PharmD
by mitsue-stanley
PGY-2 Oncology Pharmacy Resident. Pharmacy Grand...
DEFINING THE DURATION OF ANTICOAGULATION
DEFINING THE DURATION OF ANTICOAGULATION
by olivia-moreira
How long to treat a DVT?. What do the ACCP Guidel...
Tumor Registry Woodard Education Grade Manual Identify Present Manual
Tumor Registry Woodard Education Grade Manual Identify Present Manual
by jaden
1. 2021 Tumor Registry UpdatesLeslie Woodard, ICRA...
Concomitant Temozolomide Plus Radiotherapy for High-grade and Recurrent Meningioma: A Retrospective
Concomitant Temozolomide Plus Radiotherapy for High-grade and Recurrent Meningioma: A Retrospective
by natalie
. Katherine Belanger BS. 1. , Timothy H. Ung MD. 1...
Neuroendocrine Tumor Chemotherapy
Neuroendocrine Tumor Chemotherapy
by bery
Dr. Ali . Okhovatian. . M.D. .. Active Member o...
Warfarin Therapy
Warfarin Therapy
by ellena-manuel
Nicolas Novitzky. The Ideal Oral Anticoagulant. I...
Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications
Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications
by calandra-battersby
An Interactive Oncology Grand Rounds Series. Joyc...
Lymphomas: Part II Non-Hodgkin’s lymphoma (NHL)
Lymphomas: Part II Non-Hodgkin’s lymphoma (NHL)
by madison
Non-Hodgkin’s lymphoma (. NHL) is a term coverin...
Instructions – delete this slide before presenting
Instructions – delete this slide before presenting
by lydia
This presentation can be used either as a complete...
Disease of vein Key points
Disease of vein Key points
by isla
2 primary functions of vein are transporting blood...
An Evaluation of Prostate Volume and Proton Therapy-Related Toxicities
An Evaluation of Prostate Volume and Proton Therapy-Related Toxicities
by catherine
Libby . Krcik. , BS, RT(T), Patrick Lee, MS, RT(T)...
R. Phillip Dellinger, MD, MCCM, FCCP
R. Phillip Dellinger, MD, MCCM, FCCP
by lois-ondreau
Acting . Chair & Chief of . Department of . M...
R. Phillip Dellinger, MD, MCCM, FCCP
R. Phillip Dellinger, MD, MCCM, FCCP
by tatiana-dople
Acting . Chair & Chief of . Department of . M...
MANUAL THERAPY
MANUAL THERAPY
by pamella-moone
IN ATHLETICS. Joel Harman D.C., Cert. MDT, CKTP. ...
Canadian Diabetes Association Clinical Practice Guidelines
Canadian Diabetes Association Clinical Practice Guidelines
by alexa-scheidler
Pharmacologic Management of Type 2 . Diabetes . C...
Furcation: The Problem and Its Management
Furcation: The Problem and Its Management
by celsa-spraggs
Dr. Shalini Kaushal. Assoc. Prof.. Periodontology...
Unwrapping Lower Extremity Ulcers
Unwrapping Lower Extremity Ulcers
by debby-jeon
Sharon D. White, BSN,RN,CWOCN. University of Alab...
2018 Data Changes Mignon Dryden, CTR
2018 Data Changes Mignon Dryden, CTR
by conchita-marotz
April 11, 2018. Region 5 Educational Meeting. Wha...
The Treatment of Sepsis:
The Treatment of Sepsis:
by debby-jeon
Early Goal Directed Therapy. and Beyond. Anthony ...
Diabetic Foot Management
Diabetic Foot Management
by oneill
DR.Ghazi. . Saeid. Introduction. Diabetes is one ...
niques for affecting transfer to a realworld setting We used the Wol
niques for affecting transfer to a realworld setting We used the Wol
by mackenzie
- ment compared with less-adherent participants. T...
CDK4-6 INHIBITORS IN Breast Cancer: Optimal Treatment Sequencing
CDK4-6 INHIBITORS IN Breast Cancer: Optimal Treatment Sequencing
by leah
Mansoor A Khan, BS, MS, BCOP. Oncology/Hematology/...
A phase 3 trial comparing talazoparib, an oral PARP inhibitor, to physician’s choice of therapy
A phase 3 trial comparing talazoparib, an oral PARP inhibitor, to physician’s choice of therapy
by bikersjoker
patients with . advanced breast . cancer and a ger...
Intensive Hemodialysis: Applied Clinical Practice
Intensive Hemodialysis: Applied Clinical Practice
by vizettan
GUIDELINES FROM. 5 MEDICAL SOCIETIES IN . NORTH AM...
Astrocytomas Stud. Francesca
Astrocytomas Stud. Francesca
by jane-oiler
Ochea. , Carol Davila University of Medicine and ...
Chimeric Antigen Receptor T-Cell Toxicity Management
Chimeric Antigen Receptor T-Cell Toxicity Management
by faustina-dinatale
Heather N. Moore, . PharmD. PGY2 Oncology Pharmac...
Non-structural causes of low back pain: Spondyloarthritis (SpA)
Non-structural causes of low back pain: Spondyloarthritis (SpA)
by tatyana-admore
Drew Trainor, DO MS FAAPMR FAAPM. dtrainor@denver...
High Grade Gliomas : Case Presentation and Summary of Evidence for Radiation Therapy Management
High Grade Gliomas : Case Presentation and Summary of Evidence for Radiation Therapy Management
by myesha-ticknor
Jonathan Klein. PGY3, . Radiation . Oncology. Uni...
Anticoagulation in Atrial
Anticoagulation in Atrial
by karlyn-bohler
Fibrillation. Michelle Tsukamoto . DSR 2 May 9, ...
Precision Medicine in the management of gynecologic cancers
Precision Medicine in the management of gynecologic cancers
by stefany-barnette
Randal West, MD. Ovarian cancer standard of care....
Anticoagulation in Atrial
Anticoagulation in Atrial
by lois-ondreau
Fibrillation. Michelle Tsukamoto . DSR 2 May 9, ...
GreenLight XPS™ Laser Therapy System
GreenLight XPS™ Laser Therapy System
by min-jolicoeur
The GOLIATH Study. The GOLIATH . Study. 1-3. Pros...
Treatment of Acute Pulmonary Embolism
Treatment of Acute Pulmonary Embolism
by calandra-battersby
Kevin Pham. May 2014. Objective. T o review the m...
Overall survival and safety experience from an expanded access program (EAP) of nivolumab (NIVO) fo
Overall survival and safety experience from an expanded access program (EAP) of nivolumab (NIVO) fo
by olivia-moreira
Milton Barros e Silva,. 1. Rafael Schmerling,. 2...
Evaluation of HR[ER/ PgR
Evaluation of HR[ER/ PgR
by pasty-toler
] status and correlation with Ki67 expression ...
R. Phillip Dellinger, MD, MCCM, FCCP
R. Phillip Dellinger, MD, MCCM, FCCP
by stefany-barnette
Acting . Chair & Chief of . Department of . M...
Symptom Management of Novel Agents
Symptom Management of Novel Agents
by yoshiko-marsland
Amanda Dean, MSN, ACNP-BC, RNFA. Director of Adva...